QQ客服 官方微博 反馈留言

	SUBSET ANALYSES OF EAST ASIAN PATIENTS ENROLLED IN THE MISSION PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF SORAFENIB MONOTHERAPY IN PATIENTS WITH ADVANCED RELAPSED/REFRACTORY NSCLC OF PREDOMINANTLY NON-SQUAMOUS HISTOLOGY WHO
	Mok, Tony S. K.; Wu, Yi-long; Zhou, Caicun; Sun, Yan; Zhang, Li; Liao, Meilin; Qin, Shukui; Seto, Takashi; Atagi, Shinji; Okamoto, Isamu
	2012
卷号	7期号:11页码:S458-S458
关键词	NSCLC sorafenib MISSION Trial East Asian
ISSN号	1556-0864
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6722514
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Mok, Tony S. K.,Wu, Yi-long,Zhou, Caicun,et al. SUBSET ANALYSES OF EAST ASIAN PATIENTS ENROLLED IN THE MISSION PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF SORAFENIB MONOTHERAPY IN PATIENTS WITH ADVANCED RELAPSED/REFRACTORY NSCLC OF PREDOMINANTLY NON-SQUAMOUS HISTOLOGY WHO[J],2012,7(11):S458-S458.
APA	Mok, Tony S. K..,Wu, Yi-long.,Zhou, Caicun.,Sun, Yan.,Zhang, Li.,...&Paz-Ares, Luis.(2012).SUBSET ANALYSES OF EAST ASIAN PATIENTS ENROLLED IN THE MISSION PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF SORAFENIB MONOTHERAPY IN PATIENTS WITH ADVANCED RELAPSED/REFRACTORY NSCLC OF PREDOMINANTLY NON-SQUAMOUS HISTOLOGY WHO.,7(11),S458-S458.
MLA	Mok, Tony S. K.,et al."SUBSET ANALYSES OF EAST ASIAN PATIENTS ENROLLED IN THE MISSION PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF SORAFENIB MONOTHERAPY IN PATIENTS WITH ADVANCED RELAPSED/REFRACTORY NSCLC OF PREDOMINANTLY NON-SQUAMOUS HISTOLOGY WHO".7.11(2012):S458-S458.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。